News | ASTRO | October 24, 2020

Conference programming for ASTRO20 began today, and runs through October 29

Conference programming for ASTRO20 began today, and runs through October 29 #ASTRO20

October 24, 2020 — The American Society of Radiation Oncology's (ASTRO) 62nd Annual Meeting launched its Exhibit Hall Only Day yesterday, a new event one day before programming begins, to provide more time for attendees to network and interact with exhibitors. More than 1,000 attendees from 60 countries participated in Exhibit Hall Only Day yesterday, visiting our more than 110 exhibitors.

Traci Conley, regional account manager with Standard Imaging, Inc. shared, “This is absolutely amazing! I stopped in the lounge this morning and it seems everyone shares the opinion…this is engaging and user-friendly. Well done to the entire ASTRO team!”

“This has been a great experience and exceeds my expectations and past experience of a virtual meeting,” said Kelly Graber, Stryker senior program manager-Tradeshow.

“This virtual Exhibit Hall is one of the best platforms I've experienced this year, and we're pleased with the amount of exposure and access it has given us. The ASTRO team always organizes a great event with quality scientific content mixed with vendor participation and social activities to provide everyone with an exceptional experience each year,” said Melanie Benton, director, Marketing, at Mevion Medical Systems.

ASTRO20 runs October 24-28, 2020, via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center.

Originally planned as an on-site meeting in Miami, the ASTRO 2020 Annual Meeting was moved to a web-based platform due to safety concerns associated with the COVID-19 pandemic. Given the large volume of new science to be unveiled, the content will be available for 30 days after the meeting ends.

"Cancer doesn’t wait, even during a pandemic. With the health and safety of cancer patients in mind, we chose to invest in an interactive platform so that we can offer attendees a complete meeting experience,” said ASTRO President Thomas J. Eichler, M.D., FASTRO. “Attendees will be able to engage with each other on live video and chat platforms and access more than 2,500 abstracts. We will have live, on-demand and interactive sessions to showcase the latest research and best practices in cancer treatment. Recognizing that many meetings were cancelled or abbreviated this year, we enhanced our educational program and will have more than 200 hours of continuing medical education (CME) credits available for 30 days after the meeting ends.”

The meeting platform includes a digital rendering of the Miami Beach Convention Center that attendees can navigate to interact with other attendees and ASTRO leadership, visit networking lounges, participate in job interviews and attend live and on-demand sessions.

For more information: ASTRO20

Related Content

News | Prostate Cancer

July 1, 2022 — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care ...

Time July 01, 2022
arrow
News | Proton Therapy

July 1, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology ...

Time July 01, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

June 30, 2022 — When a patient with head and neck cancer has surgery to remove it, they often need reconstructive ...

Time June 30, 2022
arrow
News | Proton Therapy

June 29, 2022 — ProtOnART builds upon the partners’ long-standing research efforts and shared ambition that an online ...

Time June 29, 2022
arrow
News | Lung Imaging

June 29, 2022 — Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor ...

Time June 29, 2022
arrow
News | Proton Therapy

June 27, 2022 — Varian, a Siemens Healthineers company, announced that the U.S. Food and Drug Administration (FDA) ...

Time June 28, 2022
arrow
News | Radiation Oncology

June 27, 2022 — Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they ...

Time June 28, 2022
arrow
News | Radiation Therapy

June 24, 2022 — Recently, a collaborated research team led by Prof. LI Hai and Hongzhi Wang from Hefei Institutes of ...

Time June 24, 2022
arrow
News | Contrast Media

June 23, 2022 — Supply chain disruptions have created critical shortages of Omnipaque (iohexol) and Visipaque (iodixanol ...

Time June 23, 2022
arrow
News | Radiation Therapy

June 23, 2022 — RaySearch Laboratories AB announced the release of the latest version of RayCare*, the next generation ...

Time June 23, 2022
arrow
Subscribe Now